Glaukos

Youtube Subscribe

Open: 49.59 Close: 49.57 Change: -0.02

The 13 top things that an AI found about Glaukos Company Inc Stock and you do not know…

This document will help you to evaluate Glaukos without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Glaukos are: Log, Glaukos, share, eye, stock, trading, Link, and the …

Concept Map

Semantic Network

Stock Summary

Glaukos Corporation focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStents that enhance aqueous humor outflow.

Today's Summary

Hedge funds now own around 92.17% of all Glaukos publicly traded shares. Minimum trading price for one share is $33.33 while maximum is set at $62.58 within a span of 52 weeks. Citigroup upping predictability for this stock from buy to target an objective price range between $57-$59.

Today's News

Glaukos nets fda ok for pressure-relieving glaucoma eye stent. iStent inject W helps preserve vision by addressing high eye pressure. Glauko is a stock to avoid completely, seeing companies under 3.5x ratios. Glaukos Corporation (GKOS) Stock Price Today, News, Quotes, FAQs and Fundamentals StockTwits Logo Join the Conversation! Build your trading network. Link your favorite assets Link Your Portfolio and become verified Sign Up Log In Log In. Log in Log In and Log in to become verified. Glaukos ( NYSE:GKOS – Get Rating ) last announced its quarterly earnings results on Wednesday, February 22nd. New York State Common Retirement Fund (NYSCRF) has made a significant move, reducing its stake. Hedge funds now own around 92.17% of all Glaukos publicly traded shares. Minimum trading price for one share is $33.33 while maximum is set at $62.58 within a span of 52 weeks. Citigroup upping predictability for this stock from buy to target an objective price range between $57-$59 per share.

Stock Profile

"Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, an implantable device intended to reduce the intraocular pressure of the eye; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo California."

Keywords

Are looking for the most relevant information about Glaukos? Investor spend a lot of time searching for information to make investment decisions in Glaukos. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Glaukos are: Log, Glaukos, share, eye, stock, trading, Link, and the most common words in the summary are: glaukos, watch, introduction, episode, rightarrow, fda, eye, . One of the sentences in the summary was: Minimum trading price for one share is $33.33 while maximum is set at $62.58 within a span of 52 weeks. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #glaukos #watch #introduction #episode #rightarrow #fda #eye.

Read more →

Youtube Subscribe

---